Auto‐antibodies Sphingosine-1-phosphate Biomarkers Autoimmune diseases Anti‐mitochondrial antibodies Prognosis Acute Kidney Injury/epidemiology/etiology Myopathy Dependovirus/genetics/immunology Skeletal muscle Autoantibodies Inborn errors of metabolism Systems biology Outcome measures Adjudication B-lymphocyte Adverse drug reactions B cell homeostasis AAV vectors Male Anti-drug antibodies Machine learning Auto-antibodies IMNM Amyotrophic lateral sclerosis Bioelectrical impedance analysis Antibody responses Agalsidase Aldosterone Adeno-associated vector Case reports Anémie hémolytique Inclusion body myositis Adult Dermatomyositis Multidisciplinarity Fabry disease Amyotrophy Inflammation Biomarker Aldostérone Anticorps spécifique des myosites Idiopathic inflammatory myopathies Myositis Active Immune checkpoint inhibitors Analyses multidimensionnelles Lysosomal storage diseases CD8+ T-bet+ cells Biomarqueurs AAV antibody Antisynthétase Anticorps anti-agalsidase Aged AAV humoral immunity Muscle Data integration Inflammatory myopathy IBM Myositis and muscle disease Abnormal movement Anti-synthetase syndrome Myocarditis Assisted communication devices Humans Polymyositis Animals AAV vector Gene therapy COVID-19 Adeno-associated virus vector Auto-immunité Antisynthetase syndrome Mass cytometry Anti-MDA5 autoantibodies Antisynthetase Antibodies DM Anti-interleukin-6 Deep immune profiling Autoantibody Biopsy Arthritis Immunotherapy Cancer Acid-alpha-glucosidase Middle Aged Autoimmunity Interstitial lung disease Anti-agalsidase antibodies CD8+T cells Cytokines Interferon Adeno-associated virus Female Antiphospholipid syndrome Anti-Mi2 Anti-IgE IgG AAV Adolescence